Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $496.45 | 7 | 57.3% |
| Food and Beverage | $269.83 | 5 | 31.1% |
| Consulting Fee | $100.00 | 1 | 11.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $496.45 | 7 | $0 (2024) |
| Boston Scientific Corporation | $125.49 | 1 | $0 (2022) |
| COMSORT, Inc | $100.00 | 1 | $0 (2019) |
| ABBVIE INC. | $59.52 | 1 | $0 (2024) |
| Teleflex LLC | $35.08 | 1 | $0 (2022) |
| Axonics, Inc. | $35.07 | 1 | $0 (2022) |
| Merck Sharp & Dohme LLC | $14.67 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $321.51 | 4 | Astellas Pharma US Inc ($261.99) |
| 2023 | $14.67 | 1 | Merck Sharp & Dohme LLC ($14.67) |
| 2022 | $195.64 | 3 | Boston Scientific Corporation ($125.49) |
| 2021 | $49.00 | 1 | Astellas Pharma US Inc ($49.00) |
| 2020 | $99.95 | 1 | Astellas Pharma US Inc ($99.95) |
| 2019 | $169.99 | 2 | COMSORT, Inc ($100.00) |
| 2018 | $15.52 | 1 | Astellas Pharma US Inc ($15.52) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $59.52 | General |
| Category: UROLOGY | ||||||
| 02/28/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 02/28/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $94.00 | General |
| 02/28/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $68.00 | General |
| 10/13/2023 | Merck Sharp & Dohme LLC | BRIDION (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2022 | Boston Scientific Corporation | General - Male SUI (Device) | Food and Beverage | In-kind items and services | $125.49 | General |
| Category: General - Male SUI_URO | ||||||
| 06/12/2022 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $35.08 | General |
| Category: Interventional Urology | ||||||
| 06/12/2022 | Axonics, Inc. | Axonics (Device), Bulkamid | Food and Beverage | In-kind items and services | $35.07 | General |
| Category: Urology | ||||||
| 04/27/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $49.00 | General |
| 12/15/2020 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.95 | General |
| 11/25/2019 | Astellas Pharma US Inc | — | Education | In-kind items and services | $69.99 | General |
| 08/01/2019 | COMSORT, Inc | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $100.00 | General |
| Category: ONCOLOGY | ||||||
| 08/20/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Education | In-kind items and services | $15.52 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 3,045 | 3,668 | $841,658 | $186,323 |
| 2022 | 22 | 2,500 | 3,152 | $721,904 | $165,964 |
| 2021 | 22 | 2,613 | 3,152 | $745,225 | $176,663 |
| 2020 | 25 | 2,387 | 2,806 | $764,873 | $167,778 |
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 204 | 260 | $201,146 | $47,823 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 258 | 307 | $115,779 | $27,138 | 23.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 116 | 133 | $70,114 | $18,591 | 26.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 274 | 286 | $76,103 | $17,709 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 124 | 124 | $72,468 | $14,764 | 20.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 78 | 78 | $59,284 | $12,958 | 21.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 180 | 191 | $31,533 | $7,750 | 24.6% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 35 | 35 | $28,248 | $6,573 | 23.3% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 177 | 187 | $22,094 | $6,228 | 28.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 63 | 63 | $23,975 | $5,051 | 21.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 52 | 54 | $6,267 | $3,865 | 61.7% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 30 | 31 | $7,163 | $3,507 | 49.0% |
| 51701 | Insertion of temporary bladder tube | Office | 2023 | 38 | 85 | $20,617 | $2,888 | 14.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 69 | 73 | $4,351 | $2,706 | 62.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 279 | 335 | $32,924 | $2,599 | 7.9% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 21 | 30 | $10,099 | $1,808 | 17.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 620 | 789 | $22,092 | $1,736 | 7.9% |
| 81003 | Automated urinalysis test | Facility | 2023 | 298 | 348 | $9,744 | $765.72 | 7.9% |
| 54235 | Injection procedure to cause erection | Office | 2023 | 12 | 12 | $4,378 | $724.30 | 16.5% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 68 | 83 | $18,570 | $549.99 | 3.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $2,986 | $526.59 | 17.6% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 37 | 152 | $1,722 | $62.20 | 3.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 158 | 213 | $164,785 | $40,093 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 257 | 306 | $114,211 | $26,853 | 23.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 113 | 139 | $70,189 | $19,198 | 27.4% |
About Dr. Dimitri Kuznetsov, MD
Dr. Dimitri Kuznetsov, MD is a Urology healthcare provider based in Port Townsend, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659473825.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dimitri Kuznetsov, MD has received a total of $866.28 in payments from pharmaceutical and medical device companies, with $321.51 received in 2024. These payments were reported across 13 transactions from 7 companies. The most common payment nature is "Education" ($496.45).
As a Medicare-enrolled provider, Kuznetsov has provided services to 10,545 Medicare beneficiaries, totaling 12,778 services with total Medicare billing of $696,728. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Port Townsend, WA
- Active Since 09/01/2006
- Last Updated 12/29/2007
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1659473825
Products in Payments
- General - Male SUI (Device) $125.49
- KEYTRUDA (Biological) $100.00
- BOTOX (Biological) $59.52
- UROLIFT (Device) $35.08
- Axonics (Device) $35.07
- XTANDI (Drug) $15.52
- BRIDION (Drug) $14.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.